Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis.

J Infect

Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Electronic address:

Published: May 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867801PMC
http://dx.doi.org/10.1016/j.jinf.2023.01.030DOI Listing

Publication Analysis

Top Keywords

acceptance safety
4
safety immunogenicity
4
immunogenicity booster
4
booster dose
4
dose inactivated
4
inactivated sars-cov-2
4
sars-cov-2 vaccine
4
vaccine adults
4
adults tuberculosis
4
acceptance
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!